Transverse colon cancer

Summary

Transverse colon cancer (MONDO:0002361) is a cancer and 2 clinical trials. A subtype of malignant colon neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	transverse colon cancer
Mondo ID	MONDO:0002361
DOID	DOID:261
ICD-10-CM	C18.4
ICD-11	315492123
SNOMED CT	363408006
UMLS	C0153434
MedGen	509290
Anatomy (UBERON)	UBERON:0001157
Is cancer (heuristic)	yes

Also known as: cancer of transverse colon · malignant neoplasm of transverse colon · malignant transverse colon neoplasm · malignant tumour of transverse colon · transverse colon cancer

Disease family

This is a subtype of malignant colon neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › intestinal disorder › large intestine disorder › colonic disorder › colonic neoplasm › malignant colon neoplasm › transverse colon cancer

Related subtypes (8): descending colon cancer, sigmoid colon cancer, colon carcinoma, cecum cancer, colon lymphoma, ascending colon cancer, colon sarcoma, metastasis from malignant tumor of colon

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

Phase	Trials
PHASE2	1
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT01861691	PHASE2	UNKNOWN	Randomized Controlled Trial Between Laparoscopic and Open Surgery in Transverse and Descending Colon Cancer Patients
NCT05061199	Not specified	COMPLETED	Resection Margin of Transverse Colon Cancer With Extracorporeal Versus Intracorporeal Anastomosis